These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009 [TBL] [Abstract][Full Text] [Related]
11. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Glazer WM; Morgenstern H; Doucette JT J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030 [TBL] [Abstract][Full Text] [Related]
12. The relationship between ECT responsiveness and subtypes of tardive dyskinesia in bipolar patients. Sandyk R Int J Neurosci; 1990 Oct; 54(3-4):315-9. PubMed ID: 2265982 [TBL] [Abstract][Full Text] [Related]
13. A prospective study of tardive dyskinesia development: preliminary results. Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353 [TBL] [Abstract][Full Text] [Related]
14. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients. Bailey LG; Maxwell S; Brandabur MM Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772 [TBL] [Abstract][Full Text] [Related]
16. A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia. Levchenko A; Kanapin A; Samsonova A; Fedorenko OY; Kornetova EG; Nurgaliev T; Mazo GE; Semke AV; Kibitov AO; Bokhan NA; Gainetdinov RR; Ivanova SA Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110134. PubMed ID: 33065217 [TBL] [Abstract][Full Text] [Related]
17. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study. Sachdev P Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837 [TBL] [Abstract][Full Text] [Related]
18. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. Lerer B; Segman RH; Tan EC; Basile VS; Cavallaro R; Aschauer HN; Strous R; Chong SA; Heresco-Levy U; Verga M; Scharfetter J; Meltzer HY; Kennedy JL; Macciardi F Int J Neuropsychopharmacol; 2005 Sep; 8(3):411-25. PubMed ID: 15857569 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of tardive dyskinesia incidence in the elderly. Saltz BL; Woerner MG; Kane JM; Lieberman JA; Alvir JM; Bergmann KJ; Blank K; Koblenzer J; Kahaner K JAMA; 1991 Nov; 266(17):2402-6. PubMed ID: 1681122 [TBL] [Abstract][Full Text] [Related]
20. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. Chouinard G; Annable L; Ross-Chouinard A; Mercier P J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):21S-26S. PubMed ID: 3220967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]